Absci Corporation (NASDAQ:ABSI) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has assumed ...

Cindy Rose, Microsoft's chief operating officer for global enterprise sales, is leaving the tech behemoth to become CEO ...

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and ...

Collaboration to create novel antibody drug candidates using Chugai's proprietary antibody engineering technologies for drug ...

Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertiseVANCOUVER, Wash., July 07, 2025 (GLOBE NEWSWIRE) -- ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbSci (ABSI – Research Report) and Sanofi (SNYNF – Research Report) with bulli ...

Absci becomes clinical stage company with ABS-101, first AI-designed biologic for IBD, beginning Phase 1 trial Preclinical data for ABS-101 demonstrates high potency and potential for quarterly ...

Absci Corp. research and ratings by Barron's. View ABSI revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.